Thomas K. Equels
2018
In 2018, Thomas K. Equels earned a total compensation of $1.2M as CEO & President at Hemispherx Biopharma, a 19% increase compared to previous year.
Compensation breakdown
| Bonus | $18,350 |
|---|---|
| Option Awards | $335,731 |
| Salary | $751,000 |
| Stock Awards | $500 |
| Other | $65,927 |
| Total | $1,171,508 |
Equels received $751K in salary, accounting for 64% of the total pay in 2018.
Equels also received $18.4K in bonus, $335.7K in option awards, $500 in stock awards and $65.9K in other compensation.
Rankings
In 2018, Thomas K. Equels' compensation ranked 8,394th out of 14,244 executives tracked by ExecPay. In other words, Equels earned more than 41.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,394 out of 14,244 | 41st |
Division Manufacturing | 3,333 out of 5,759 | 42nd |
Major group Chemicals And Allied Products | 1,250 out of 2,122 | 41st |
Industry group Drugs | 1,044 out of 1,811 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 196 out of 339 | 42nd |
Source: SEC filing on August 20, 2019.
Equels' colleagues
We found two more compensation records of executives who worked with Thomas K. Equels at Hemispherx Biopharma in 2018.